Metraipolis › archive › dc_28ae99211197

Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2… — Europe PMC PMID:42512265

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42512265
DOI
10.3390/cancers18142198
License (as archived)
solo-consultazione
Archived
2026-10-18T10:18:47.892Z
SHA-256 of the archived text
c3c10e6c6ee6193dffa5ee67ca090f6631e09520ff05e95a859009890fa8a57a
Stable URL of this page
https://metraipolis.com/documento/dc_28ae99211197

How to cite

Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2… — Europe PMC PMID:42512265 — Europe PMC (en), https://europepmc.org/article/MED/42512265 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28ae99211197 (Metraipolis archive dc_28ae99211197, sha256 c3c10e6c6ee6193dffa5ee67ca090f6631e09520ff05e95a859009890fa8a57a)
BibTeX
@misc{dc28ae99211197,
  title = {Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2… — Europe PMC PMID:42512265},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512265},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28ae99211197; sha256 c3c10e6c6ee6193dffa5ee67ca090f6631e09520ff05e95a859009890fa8a57a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512265. Agents can read the archived copy with the MCP tool read_document.